YOLOv8n-BWG-enhanced drone smoke detection: Advancing environmental monitoring efficiency by Yaojun Zhang, Guiling Wu

Get full text

Current Status and Future of Multidisciplinary Team in Hepatocellular Carcinoma by Jinbin CHEN, Yaojun ZHANG, Minshan CHEN

Get full text

Transarterial therapy combined with bevacizumab plus immune checkpoint inhibitors as a neoadjuvant therapy for locally advanced HCC by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Qianyu Wang, Li Hu, Li Hu, Li Hu, Xiaoxian Sima, Xiaoxian Sima, Xiaoxian Sima, Juncheng Wang, Juncheng Wang, Juncheng Wang, Dandan Hu, Dandan Hu, Dandan Hu, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Minshan Chen, Minshan Chen, Minshan Chen, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Yizhen Fu, Yizhen Fu, Yizhen Fu

Get full text

PD-1 inhibitor-augmented HAIC-TKI therapy in hepatocellular carcinoma with portal vein tumor thrombosis: real-world survival benefits, safety, and subgroup-specific efficacy by Fei Cao, Fei Cao, Fei Cao, Fei Cao, Chunyong Wen, Chunyong Wen, Chunyong Wen, Chunyong Wen, Yujia Wang, Yujia Wang, Yujia Wang, Yujia Wang, Hongtong Tan, Hongtong Tan, Hongtong Tan, Hongtong Tan, Shaohuan Hao, Jinbin Chen, Jinbin Chen, Jinbin Chen, Jinbin Chen, Shuanggang Chen, Shuanggang Chen, Shuanggang Chen, Shuanggang Chen, Lujun Shen, Lujun Shen, Lujun Shen, Lujun Shen, Lin Xie, Lin Xie, Lin Xie, Lin Xie, Han Qi, Han Qi, Han Qi, Han Qi, Tao Huang, Tao Huang, Tao Huang, Tao Huang, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Zilin Huang, Zilin Huang, Zilin Huang, Zilin Huang

Get full text

Comparison of lenvatinib plus pembrolizumab versus first-line systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a real-world retrospective study by Zhenyun Yang, Zhenyun Yang, Zhenyun Yang, Weijie Wu, Weijie Wu, Weijie Wu, Zhiwen Hu, Zhiwen Hu, Zhiwen Hu, Yizhen Fu, Yizhen Fu, Yizhen Fu, Zili Hu, Zili Hu, Zili Hu, Yangxun Pan, Yangxun Pan, Yangxun Pan, Juncheng Wang, Juncheng Wang, Juncheng Wang, Jinbin Chen, Jinbin Chen, Jinbin Chen, Zhongguo Zhou, Zhongguo Zhou, Zhongguo Zhou, Yaojun Zhang, Yaojun Zhang, Yaojun Zhang, Minshan Chen, Minshan Chen, Minshan Chen, Dandan Hu, Dandan Hu, Dandan Hu

Get full text

Lenvatinib versus bevacizumab when combined with PD-1/L1 inhibitor and hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma by Lichang Huang, Yujie Xu, Na Liu, Hailong Chen, Zichao Wu, Qijiong Li, Minqiang Lu, Wei Wei, Yaojun Zhang, Minshan Chen, Li Xu, Ming Shi, Zhicheng Lai

Get full text

YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment by Zhenyun Yang, Xin Wang, Yizhen Fu, Weijie Wu, Zili Hu, Qingyang Lin, Wei Peng, Yangxun Pan, Juncheng Wang, Jinbin Chen, Dandan Hu, Zhongguo Zhou, Li Xu, Yaojun Zhang, Jiajie Hou, Minshan Chen

Get full text

Cost-effectiveness of angiographic quantitative flow ratio-guided coronary intervention: A multicenter, randomized, sham-controlled trial by Yanyan Zhao, Changdong Guan, Yang Wang, Zening Jin, Bo Yu, Guosheng Fu, Yundai Chen, Lijun Guo, Xinkai Qu, Yaojun Zhang, Kefei Dou, Yongjian Wu, Weixian Yang, Shengxian Tu, Javier Escaned, William F. Fearon, Shubin Qiao, David J. Cohen, Harlan M. Krumholz, Bo Xu, Lei Song, On behalf of FAVOR III China Study Group, Ting Gao

Get full text

Myeloid response evaluated by noninvasive CT imaging predicts post-surgical survival and immune checkpoint therapy benefits in patients with hepatocellular carcinoma by Kangqiang Peng, Xiao Zhang, Xiao Zhang, Zhongliang Li, Yongchun Wang, Yongchun Wang, Hong-Wei Sun, Wei Zhao, Wei Zhao, Jielin Pan, Jielin Pan, Xiao-Yang Zhang, Xiaoling Wu, Xiangrong Yu, Xiangrong Yu, Chong Wu, Yulan Weng, Xiaowen Lin, Dingjie Liu, Dingjie Liu, Meixiao Zhan, Meixiao Zhan, Jing Xu, Limin Zheng, Limin Zheng, Yaojun Zhang, Ligong Lu, Ligong Lu

Get full text